Cargando…
PULSED METHYLPREDNISOLONE USAGE IN ARDS DUE TO VIRAL PNEUMONIA
Autor principal: | Szeto, C.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130207/ http://dx.doi.org/10.1016/j.chest.2019.02.365 |
Ejemplares similares
-
A COMPARISON OF PULSE METHYLPREDNISOLONE TO LOW-DOSE METHYLPREDNISOLONE IN CRITICALLY-ILL PATIENTS WITH SARS-COV-2 PNEUMONIA: RETROSPECTIVE, OBSERVATIONAL STUDY
por: Bidin, F.N., et al.
Publicado: (2023) -
Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children
por: Tamura, Akihiro, et al.
Publicado: (2008) -
Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children
por: You, Sun Young, et al.
Publicado: (2014) -
CMV reactivation caused by methylprednisolone therapy for ARDS after esophagectomy
por: Sato, Yusuke, et al.
Publicado: (2012) -
Is the treatment with pulses of methylprednisolone safe?
por: Bednarczuk, Tomasz, et al.
Publicado: (2013)